Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension

被引:122
作者
Louis, CA
Reichner, JS
Henry, WL
Mastrofrancesco, B
Gotoh, T
Mori, M
Albina, JE
机构
[1] Rhode Isl Hosp, Dept Surg, Div Surg Res, Providence, RI 02903 USA
[2] Brown Univ, Sch Med, Providence, RI 02903 USA
[3] Kumamoto Univ, Sch Med, Dept Mol Genet, Kumamoto 862, Japan
关键词
arginine; macrophage; hypoxia;
D O I
10.1152/ajpregu.1998.274.3.R775
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Experiments were performed to identify arginase isoforms expressed in primary and transformed rodent macrophages and to determine the molecular mechanisms for the previously observed increase in arginase activity in macrophages cultured in hypoxia or anoxia. Results demonstrate the following: 1) mRNA and protein for hepatic-type Al arginase are expressed in primary cultures of rat and mouse peritoneal macrophages and are enhanced seven-and ninefold, respectively, by lipopolysaccharide (LPS). 2) mRNA for extrahepatic-type AII arginase is constitutively expressed in mouse, but not rat, peritoneal macrophages and is detected in RAW264.7 cells after LPS treatment; neither J774A.1 nor P388D(1) cells contain arginase mRNA. 3) AI arginase mRNA, arginase activity in cell lysates, and L-arginine flux through arginase in intact cells are all increased in rat wound-derived and mouse peritoneal macrophages by hypoxide or anoxic culture; AII arginase mRNA is, in contrast, suppressed >50% by O-2 deprivation. 4) Expression of the L-arginine transporter mCAT-2 is increased greater than twofold by reduced O-2 culture. These results demonstrate substantial variability in arginase isoform expression among primary and transformed rodent macrophages, They also identify AI and AII arginase and the mCAT-2 L-arginine transporter as O-2-regulated genes.
引用
收藏
页码:R775 / R782
页数:8
相关论文
共 42 条
[1]  
Albina J E, 1995, New Horiz, V3, P46
[2]   ARGININE METABOLISM IN WOUNDS [J].
ALBINA, JE ;
MILLS, CD ;
BARBUL, A ;
THIRKILL, CE ;
HENRY, WL ;
MASTROFRANCESCO, B ;
CALDWELL, MD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (04) :E459-E467
[3]  
ALBINA JE, 1995, J IMMUNOL, V155, P4391
[4]   SUPPRESSION OF LYMPHOCYTE-PROLIFERATION THROUGH THE NITRIC-OXIDE SYNTHESIZING PATHWAY [J].
ALBINA, JE ;
HENRY, WL .
JOURNAL OF SURGICAL RESEARCH, 1991, 50 (04) :403-409
[5]  
ALBINA JE, 1991, J IMMUNOL, V147, P144
[6]  
ALBINA JE, 1990, J IMMUNOL, V144, P3877
[7]   PURIFICATION, AFFINITY TO ANTI-HUMAN ARGINASE IMMUNOGLOBULIN-SEPHAROSE 4B AND SUBUNIT MOLECULAR-WEIGHTS OF MAMMALIAN ARGINASES [J].
BRUSDEILINS, M ;
KUHNER, R ;
SCHUMACHER, K .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 840 (01) :79-90
[8]   MUTAGENESIS OF RAT-LIVER ARGINASE EXPRESSED IN ESCHERICHIA-COLI - ROLE OF CONSERVED HISTIDINES [J].
CAVALLI, RC ;
BURKE, CJ ;
KAWAMOTO, S ;
SOPRANO, DR ;
ASH, DE .
BIOCHEMISTRY, 1994, 33 (35) :10652-10657
[9]  
CHEN PC, 1980, P SOC EXP BIOL MED, V163, P354
[10]   CCAAT/enhancer-binding protein beta (C/EBP beta) binds and activates while hepatocyte nuclear factor-4 (HNF-4) does not bind but represses the liver-type arginase promoter [J].
Chowdhury, S ;
Gotoh, T ;
Mori, M ;
Takiguchi, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (02) :500-509